trending Market Intelligence /marketintelligence/en/news-insights/trending/VvBZZ_Xj_mwT2cHGjYqv4w2 content esgSubNav
In This List

US FDA approves Anika's bone repair treatment

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


US FDA approves Anika's bone repair treatment

The U.S. Food and Drug Administration approved Anika Therapeutics, Inc.'s injectable bone repair treatment.

The U.S. regulator granted 510(k) clearance to the company's injectable hyaluronic acid-based bone void filler for filling bone voids or defects of the skeletal system.

The bone void filler is resorbed and replaced by the growth of new bone during the healing process.